Search
InsiderInsights.com

Stein Jeffrey (1478831)

Stein Jeffrey has been a registered insider at 3 firms since 2010. As Chief Executive Officer at Cidara Therapeutics, Stein Jeffrey last made a transaction on 3/27/2023. As a Director at Transcept Pharmaceuticals, Inc., Stein Jeffrey last made a transaction on 2/21/2023. As Chief Executive Officer at Trius Therapeutics, Inc. , Stein Jeffrey last made a transaction on 3/27/2012.

(CDTX)

Titles: PR,CEO,DIR

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
14 7% -31% -36% 128 1 Year 14 0% -- -- --
14 21% -19% -23% 190 9 Month 14 0% -- -- --
14 43% -11% -3% 106 6 Month 14 0% -- -- --
14 36% -7% -10% 94 3 Month 14 0% -- -- --
15 60% 0% 2% 46 1 Month 15 0% -- -- --
15 53% 3% 3% 34 1 Week 15 0% -- -- --
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
-- -- -- -- -- 1 Year -- -- -- -- --
-- -- -- -- -- 9 Month -- -- -- -- --
-- -- -- -- -- 6 Month -- -- -- -- --
-- -- -- -- -- 3 Month -- -- -- -- --
-- -- -- -- -- 1 Month -- -- -- -- --
-- -- -- -- -- 1 Week -- -- -- -- --
Scorecards Updated 6/14/2023 12:10 AM EST Latest Transaction Date: 3/27/2023
Average days between Transaction and Entered Dates: 2

Paratek Pharmaceuticals, Inc. (TSPT, PRTK, NOVC.old)

Titles: DIR

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
-- -- -- -- -- 1 Year -- -- -- -- --
-- -- -- -- -- 9 Month -- -- -- -- --
-- -- -- -- -- 6 Month -- -- -- -- --
-- -- -- -- -- 3 Month -- -- -- -- --
-- -- -- -- -- 1 Month -- -- -- -- --
-- -- -- -- -- 1 Week -- -- -- -- --
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
1 100% -50% -- -- 1 Year 1 0% -- -- --
1 100% -58% -- -- 9 Month 1 0% -- -- --
1 100% -43% -- -- 6 Month 1 0% -- -- --
2 100% -26% -26% 30 3 Month 2 0% -- -- --
2 100% -14% -14% 10 1 Month 2 0% -- -- --
2 50% -1% -1% 4 1 Week 2 0% -- -- --
Scorecards Updated 6/14/2023 12:10 AM EST Latest Transaction Date: 2/21/2023
Average days between Transaction and Entered Dates: 4

Trius Therapeutics Inc (TSRX)

Titles: PR,CEO,DIR

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
2 100% 67% 67% 61 1 Year 2 0% -- -- --
2 50% 42% 42% 92 9 Month 2 0% -- -- --
2 100% 70% 70% 111 6 Month 2 0% -- -- --
2 100% 37% 37% 44 3 Month 2 0% -- -- --
2 100% 15% 15% 26 1 Month 2 0% -- -- --
2 100% 3% 3% 3 1 Week 2 0% -- -- --
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
-- -- -- -- -- 1 Year -- -- -- -- --
-- -- -- -- -- 9 Month -- -- -- -- --
-- -- -- -- -- 6 Month -- -- -- -- --
-- -- -- -- -- 3 Month -- -- -- -- --
-- -- -- -- -- 1 Month -- -- -- -- --
-- -- -- -- -- 1 Week -- -- -- -- --
Scorecards Updated 6/14/2023 12:10 AM EST Latest Transaction Date: 3/27/2012
Average days between Transaction and Entered Dates: 2
© 2024 InsiderInsights.com